medical affairs responsibilities

4.8.2014 Medical Affairs

The Demand for and Implementation of Medical Publications Transparency

By Christie Shilling, Research Analyst I play video games often in my free time and hold a particular love for the Portal series.  At the end of the first game, there is a cute song that contains the line, “We do what we must because we can.” ...
 

4.2.2014 Medical Affairs

Making the Most of Scientific Advisory Boards with Clear Objectives

By Jacob Presson, Research Analyst When bringing together a group of active clinicians and specialists for a scientific advisory board, companies should make sure to maximize the effectiveness of the resources seated around the table.  Each person...
 

1.15.2014 Medical Affairs

Medical Affairs Embracing a Patient-Centric 2014

By Nicole May, Research Analyst As pharma moves into 2014, new technologies will allow medical affairs teams to shape their strategies to be increasingly and innovatively patient-centric.  Although a case could be made to stop using the term, whatever...
 

12.23.2013 Medical Affairs

Recent Update to ICMJE Guidelines Emphasizes Author Accountability

By Sarah Ray, Research Analyst Medical publications represent a unique forum in which the medical and commercial objectives of pharmaceutical companies may, at times, overlap.  One of the primary roles of medical publications is to describe clinical...
 

10.3.2013 KOL Management

Discussion Leader and Clear Goals Set Pharmaceutical Advisory Boards Up for Success

By Yanis Saradjian, Director of Consulting The pharmaceutical industry has always turned to experts and key opinion leaders to shape and inform company policy.  Despite increasing rules on how companies are allowed to interact with physicians,...
 

10.1.2013

The Headaches Behind Warning Labels: Tylenol Put Patients First, Brand Second

By Jennifer Harrell, Research Analyst “A flat prediction I’ll make,” claimed esteemed advertising guru Jerry Della Femina in a New York Times article written in October 1982, just days after arsenic-laced Tylenol fatally poisoned seven Chicagoans,...
 

7.9.2013 Medical Affairs

Global Pharmas in Disagreement about Medical Education Budgets

By Natalie DeMasi, Research Analyst Medical education has been and continues to be a critical segment of a medical affairs team’s mission.  However, the jury is still out in regard to how much time and money a company should devote to it. In...
 

5.1.2013 Medical Affairs

Product Launch: A Busy Time for Medical Affairs Teams

Marketing and commercial teams get a lot of the credit for a successful product launch, but medical affairs teams are typically buzzing with activity in the months (sometimes even years) preceding drug approval.  As the official communication channel between a...
 

4.1.2013 Medical Affairs

Asia and the Medical Affairs Function

Regardless of company size, establishing operations to support expansions in new territories has a big impact on existing organizational structures.  The question often rests on how the subsidiary will be connected to the headquarters. Will it be a centralized...
 

1.18.2013 Medical Affairs

Medical Publications Teams Worthy of Funding

With tightening restrictions on how marketing and sales reps can interact with physicians, medical publication has become a vital task for communicating clinical information from drug companies to physicians. While publications help companies reach anywhere from...